Abraxane News
Drugs
> Abraxane
Abraxane News is an EIN News Service for health professionals. Constantly updated news and information about health.
- 4 Platform Drugmakers to Invest In 24 Nov 2009 20:53 GMT
... pool or '70s night at the disco. Drugmakers are using the same patented technology -- ... population that sometimes has trouble taking daily medication. also has a partnership with Johnson & ... The company already had one drug approved, Abraxane, which uses the company's (nanoparticle-albumin bound) technology ...
- Genasense® Given as High-Dose IV Infusion with Chemotherapy Shows Promising Activity in Advanced Melanoma 23 Nov 2009 15:40 GMT
... Data Presented at International Melanoma Conference in Berlin Results ... Plough, Inc.), the most commonly used anticancer drug for melanoma, and Abraxane® (paclitaxel protein-bound particles ... confirmed partial responses after the first 2 treatment cycles with current durations lasting from 24 ...
- Genasense® Given as High-Dose IV Infusion with Chemotherapy Shows Promising Activity in Advanced Melanoma 23 Nov 2009 16:12 GMT
... Data Presented at International Melanoma Conference in Berlin Results ... Plough, Inc.), the most commonly used anticancer drug for melanoma, and Abraxane® (paclitaxel protein-bound particles ... confirmed partial responses after the first 2 treatment cycles with current durations lasting from 24 ...
- Stockguru.com: Genta Inc. is in the StockGuru Spotlight for November 23, 2009 23 Nov 2009 10:57 GMT
... focused on delivering innovative products for the treatment of patients with cancer. Two major programs ... Plough, Inc.), the most commonly used anticancer drug for melanoma, and Abraxane (paclitaxel protein-bound particles for injectable suspension [albumen ...
- PennyOmega Announces Stock Alert on CVAT, GETA, HZHI 25 Nov 2009 08:50 GMT
... PennyOmega Announces Stock Alert on CVAT, GETA, HZHI ... vegetable oil refining, renewable fuel, petroleum, water treatment, wastewater sanitation, food and beverage, and chemical ... Plough, Inc.), the most commonly used anticancer drug for melanoma, and Abraxane(R) (paclitaxel protein-bound particles ...
- Genasense Given as High-Dose IV Infusion with Chemotherapy Shows Promising Activity in Advanced Melanoma 20 Nov 2009 13:44 GMT
... Plough, Inc.), the most commonly used anticancer drug for melanoma, and Abraxane (paclitaxel protein-bound particles for injectable suspension [albumen ... confirmed partial responses after the first 2 treatment cycles with current durations lasting from 24 ...
- www.standoutstocks.com: Stocks That Stand Out For Nov. 20th, 2009 Are RFMD, GETA, CLDS, HESG 20 Nov 2009 18:59 GMT
... Nov 20, 2009 (M2 PRESSWIRE via COMTEX) -- www.Standoutstocks.com: Stocks ... Plough, Inc.), the most commonly used anticancer drug for melanoma, and Abraxane(R) (paclitaxel protein-bound particles ... confirmed partial responses after the first 2 treatment cycles with current durations lasting from 24 ...
- Genasense(R) Given as High-Dose IV Infusion with Chemotherapy Shows Promising Activity in Advanced Melanoma 20 Nov 2009 13:41 GMT
... Data Presented at International Melanoma Conference in Berlin Results ... Plough, Inc.), the most commonly used anticancer drug for melanoma, and Abraxane(R) (paclitaxel protein-bound particles ... confirmed partial responses after the first 2 treatment cycles with current durations lasting from 24 ...
- Genasense® Given as High-Dose IV Infusion with Chemotherapy Shows Promising Activity in Advanced Melanoma 20 Nov 2009 13:46 GMT
... Plough, Inc.), the most commonly used anticancer drug for melanoma, and Abraxane (paclitaxel protein-bound particles for injectable suspension [albumen ... confirmed partial responses after the first 2 treatment cycles with current durations lasting from 24 ...
- Check Us Out!!! Sign Up Now For Our Free Newsletter!! BRGO,QSAP,XCEL,XMDC,MTVO,GETA 20 Nov 2009 18:59 GMT
... Check Us Out!!! Sign Up Now For Our Free ... Plough, Inc.), the most commonly used anticancer drug for melanoma, and Abraxane(R) (paclitaxel protein-bound particles ... confirmed partial responses after the first 2 treatment cycles with current durations lasting from 24 ...
- OTC ADVISORS, LLC: Huge Stock News Alert On - (OTCBB:BRGO) - (OTCBB:GETA) - (OTCBB:ARTS) 20 Nov 2009 16:59 GMT
... OTC ADVISORS, LLC: Huge Stock News Alert On - ... focused on delivering innovative products for the treatment of patients with cancer. Two major programs ... effectiveness of current anticancer therapy. The leading drug in Genta's Small Molecule program is Ganite(R) ...
- Genasense(R) Given as High-Dose IV Infusion with Chemotherapy Shows Promising Activity in Advanced Melanoma (BIZ) 20 Nov 2009 13:40 GMT
... (Temodar ), the most commonly used anticancer drug for melanoma, and Abraxane (paclitaxel protein-bound particles for injectable suspension [albumen ... confirmed partial responses after the first 2 treatment cycles with current durations lasting from 24 ...
- Nebula Stocks LLC: Nebulastocks.com : Presents Exciting Picks That Make Astronomical Gains Brings You - Genta Incorporated OTCBB: GETA.OB 20 Nov 2009 14:59 GMT
... Plough, Inc.), the most commonly used anticancer drug for melanoma, and Abraxane (paclitaxel protein-bound particles for injectable suspension [albumen ... confirmed partial responses after the first 2 treatment cycles with current durations lasting from 24 ...
- Genta announces preliminary results from study of Genasense Injection for advanced melanoma 20 Nov 2009 14:57 GMT
... Plough, Inc.), the most commonly used anticancer drug for melanoma, and Abraxane (paclitaxel protein-bound particles for injectable suspension [albumen ... confirmed partial responses after the first 2 treatment cycles with current durations lasting from 24 ...
- GETA, Its Genasense with Chemotherapy Shows Promising Activity in Advanced Melanoma. Hot Stock Alert by 22 Nov 2009 06:53 GMT
... PennyOmega.com is pleased to announce its X-Tra Hot ... focused on delivering innovative products for the treatment of patients with cancer. Preliminary results shows ... Plough, Inc.), the most commonly used anticancer drug for melanoma, and Abraxane® (paclitaxel protein-bound particles ...
Powered by 
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>>
| |
Healthcare Industry Today
|